Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

Gut microbiota / Evidence-based microbiome knowledge (incl. AI chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Lacticaseibacillus rhamnosus & Adiposity / Obesity

Welcome to meRfi-GM!

Please register to continue your trial period!

meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Lacticaseibacillus rhamnosus has been studied for its effects on adiposity and obesity, with some evidence suggesting beneficial impacts on body weight and fat mass in both preclinical and clinical studies.

Clinical data:

For the double-blind, randomized clinical phase I/II treatment trial ( Parallel Assignment) NCT01870544 no published data were found as of September 2025

The randomized, double-blind, placebo-controlled clinical phase II treatment trial NCT02962583 shows that supplementing with [Lactic…

References (Sources)

Lacticaseibacillus rhamnosus HA-114 improves eating behaviors and mood-related factors in adults with overweight during weight loss: a randomized controlled trial
Choi et al. 2022 Nutritional Neuroscience 26(7): 667-679
Probiotic therapy outcomes in body composition of children and adolescent with obesity, a nonrandomized controlled trial
Marcelo et al. 2022 Arch Endocrinol Metab 66(6): 815-822

AI Chat

5/29/2026

Chat with our artificial intelligence:

Start chat!